Endocervical adenocarcinoma of the gastric type: a case report and literature review
Gastric-type endocervical adenocarcinoma (G-EAC) is the most common type of non-human papillomavirus (HPV)-related cervical cancer. Specifically, G-EAC is highly malignant, has a poor prognosis, and is often missed or misdiagnosed, underscoring the need for caution. Herein, we report a case of a pat...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1457253/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Gastric-type endocervical adenocarcinoma (G-EAC) is the most common type of non-human papillomavirus (HPV)-related cervical cancer. Specifically, G-EAC is highly malignant, has a poor prognosis, and is often missed or misdiagnosed, underscoring the need for caution. Herein, we report a case of a patient with G-EAC who underwent surgery, postoperative chemoradiotherapy, targeted therapy, and immunotherapy. Clinical symptoms such as vaginal aqueous secretion and elevated serum carbohydrate antigen-19-9 (CA19-9) levels may aid in diagnosing G-EAC. Of note, in PD-1-negative G-EAC patients, immunotherapy could offer potential benefits. Raising awareness and vigilance regarding this disease, along with developing highly specific antibodies for its early diagnosis, is crucial for improving patient outcomes. |
|---|---|
| ISSN: | 2234-943X |